Integrated Pediatric Intensive Care and Hematopoietic Stem Cell Transplantation Service Improves The Peri-Transplant Survival In Children.

Nalla Anuraag Reddy, Rachit Mehta, Indira Jayakumar, Anupama Nair, Vijayshree Muthukumar, Suresh Duraisamy, Venkateswaran Vellaichamy Swaminathan, Ramya Uppuluri, Revathi Raj
{"title":"Integrated Pediatric Intensive Care and Hematopoietic Stem Cell Transplantation Service Improves The Peri-Transplant Survival In Children.","authors":"Nalla Anuraag Reddy, Rachit Mehta, Indira Jayakumar, Anupama Nair, Vijayshree Muthukumar, Suresh Duraisamy, Venkateswaran Vellaichamy Swaminathan, Ramya Uppuluri, Revathi Raj","doi":"10.31547/bct-2024-014","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Peri-transplant is a critical period which is associated with a myriad of complications that require pediatric intensive care unit (PICU) referral. PICU outcomes have been historically poor post-hematopoietic stem cell transplantation (HSCT), especially when associated with inotrope support, invasive ventilation, and renal replacement therapy. The study aimed to assess the outcomes of PICU referral in children undergoing HSCT.</p><p><strong>Patients & methods: </strong>A retrospective analysis was performed of children between 1 to 18 years of age who underwent HSCT between 2016 to 2023. A clinical deteriorating event (CDE) was defined as an unplanned transfer to the intensive care unit (ICU) or requiring ICU-level intervention on the floor. The reason for PICU referral, place of intervention, cause for the CDE, and requirement of respiratory, renal, and cardiac support were noted. The study period was divided into two 4-year intervals to assess change over time, 2016-2019 and 2020-2023.</p><p><strong>Results: </strong>In an eight-year period, a total of 934 HSCTs were performed, with 272 patients requiring PICU referral. A total of 415 CDEs were recorded. CDEs for PICU referrals were hypotension (43%), disproportionate tachycardia (42%), respiratory distress (26%), hypertension (22%), altered sensorium (8%), seizures (7.4%), and major bleeds (7.3%). Overall peri-transplant survival was 73.8% (n=201/272). Comparing the two study intervals, 2016-2019 and 2020-2023, the survival of patients on mechanical ventilation had improved from 4.5% to 27.5% (<i>p</i>=0.005) and from 39.4% to 55.9% (<i>p</i>=0.11) among those who received inotropes. Patients with three organ dysfunctions had worse outcomes. Disproportionate tachycardia [OR 0.19 CI 95% (0.06-0.64); <i>p</i>=0.008], hypotension [OR 0.177 CI 95% (0.04-0.84); <i>p</i>=0.029] and acute GVHD [OR 28.46 CI 95% (3.66-221); <i>p</i>=0.001] were significant risk factors for peri-transplant mortality as per multivariate analysis.</p><p><strong>Conclusion: </strong>Integrated care with the PICU team is the first step towards improving survival in these critically ill children. With timely intervention on the floors for CDEs and protocol-driven care in the PICU, we have demonstrated an increase in overall survival over the past four years and would recommend similar team-based care for units catering to children.</p>","PeriodicalId":72423,"journal":{"name":"Blood cell therapy","volume":"8 1","pages":"173-180"},"PeriodicalIF":0.0000,"publicationDate":"2025-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11883477/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Blood cell therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31547/bct-2024-014","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Peri-transplant is a critical period which is associated with a myriad of complications that require pediatric intensive care unit (PICU) referral. PICU outcomes have been historically poor post-hematopoietic stem cell transplantation (HSCT), especially when associated with inotrope support, invasive ventilation, and renal replacement therapy. The study aimed to assess the outcomes of PICU referral in children undergoing HSCT.

Patients & methods: A retrospective analysis was performed of children between 1 to 18 years of age who underwent HSCT between 2016 to 2023. A clinical deteriorating event (CDE) was defined as an unplanned transfer to the intensive care unit (ICU) or requiring ICU-level intervention on the floor. The reason for PICU referral, place of intervention, cause for the CDE, and requirement of respiratory, renal, and cardiac support were noted. The study period was divided into two 4-year intervals to assess change over time, 2016-2019 and 2020-2023.

Results: In an eight-year period, a total of 934 HSCTs were performed, with 272 patients requiring PICU referral. A total of 415 CDEs were recorded. CDEs for PICU referrals were hypotension (43%), disproportionate tachycardia (42%), respiratory distress (26%), hypertension (22%), altered sensorium (8%), seizures (7.4%), and major bleeds (7.3%). Overall peri-transplant survival was 73.8% (n=201/272). Comparing the two study intervals, 2016-2019 and 2020-2023, the survival of patients on mechanical ventilation had improved from 4.5% to 27.5% (p=0.005) and from 39.4% to 55.9% (p=0.11) among those who received inotropes. Patients with three organ dysfunctions had worse outcomes. Disproportionate tachycardia [OR 0.19 CI 95% (0.06-0.64); p=0.008], hypotension [OR 0.177 CI 95% (0.04-0.84); p=0.029] and acute GVHD [OR 28.46 CI 95% (3.66-221); p=0.001] were significant risk factors for peri-transplant mortality as per multivariate analysis.

Conclusion: Integrated care with the PICU team is the first step towards improving survival in these critically ill children. With timely intervention on the floors for CDEs and protocol-driven care in the PICU, we have demonstrated an increase in overall survival over the past four years and would recommend similar team-based care for units catering to children.

Abstract Image

Abstract Image

综合儿科重症监护和造血干细胞移植服务提高儿童移植围期生存率。
背景:移植周围是一个关键时期,与无数并发症相关,需要儿科重症监护病房(PICU)转诊。PICU的结果在造血干细胞移植(HSCT)后一直很差,特别是当与肌力支持、有创通气和肾脏替代治疗相关时。该研究旨在评估接受HSCT的儿童PICU转诊的结果。患者和方法:回顾性分析了2016年至2023年间接受HSCT的1至18岁儿童。临床恶化事件(CDE)被定义为意外转移到重症监护病房(ICU)或需要ICU级别的地板干预。注意转介PICU的原因、干预地点、CDE的原因以及呼吸、肾脏和心脏支持的需求。研究期间分为2016-2019年和2020-2023年两个4年间隔,以评估随时间的变化。结果:在8年期间,共进行了934例hsct,其中272例患者需要PICU转诊。共记录了415例cde。PICU转诊的cde包括低血压(43%)、不成比例的心动过速(42%)、呼吸窘迫(26%)、高血压(22%)、感觉改变(8%)、癫痫发作(7.4%)和大出血(7.3%)。总移植期生存率为73.8% (n=201/272)。对比2016-2019年和2020-2023年这两个研究区间,机械通气患者的生存率从4.5%提高到27.5% (p=0.005),接受肌力疗法患者的生存率从39.4%提高到55.9% (p=0.11)。三个器官功能障碍的患者预后更差。不成比例的心动过速[OR 0.19 CI 95% (0.06-0.64);p=0.008],低血压[OR 0.177 CI 95% (0.04-0.84);p=0.029]和急性GVHD [OR 28.46 CI 95% (3.66-221);P =0.001]是移植期死亡率的重要危险因素。结论:PICU团队的综合护理是提高危重患儿生存率的第一步。通过对cde的及时干预和PICU的协议驱动型护理,我们已经证明在过去四年中,总体生存率有所提高,并将推荐类似的以团队为基础的儿童护理单位。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信